EIGHTH AMENDMENT TO LICENSE AGREEMENTLicense Agreement • April 9th, 2019 • PhaseBio Pharmaceuticals Inc • Pharmaceutical preparations
This Eighth Amendment to License Agreement (''Amendment") is made and entered into as of March 5, 2019 (the "Amendment Date"), by and between Duke University, a North Carolina not-for-profit corporation ("Duke"), and PhaseBio Pharmaceuticals, Inc., a Delaware corporation ("Licensee").
